Role of Tranexamic Acid in Obstetrics and Gynecology
Article Sidebar
Main Article Content
Abstract
Tranexamic acid is a synthetic lysine derivative that exerts an antifibrinolytic effect by reversibly blocking the lysine binding sites on plasminogen, thus preventing fibrin degradation. It has been approved by Food and Drug Administration for treatment of heavy menstrual bleeding and short-term prevention in patients with hemophilia. However, the role of tranexamic acid in obstetrics and gynecology is promising. This review aims to explore the role of tranexamic acid in obstetrics and gynecology.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 2003;63:1417-33.
Grassin-Delyle S, Semeraro M, Lamy E, Urien S, Runge I, Foissac F, et al. Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers. Br J Anaesth 2022;128:465-72.
Tranexamic acid [Available from: mims.com/thailand/drug/info/transamin/indications.
Lysteda FDA Approval History [Available from: https://www.drugs.com/history/lysteda.html.
Cyklokapron [Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/019281s047lbl.pdf.
Kashani BN, Centini G, Morelli SS, Weiss G, Petraglia F. Role of Medical Management for Uterine Leiomyomas. Best Pract Res Clin Obstet Gynaecol 2016;34:85-103.
Tranexamic acid (Lysteda) for treatment of menorrhagia. Med Lett Drugs Ther 2010;52:54-5.
Casati V, Bellotti F, Gerli C, Franco A, Oppizzi M, Cossolini M, et al. Tranexamic acid administration after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled study. Anesthesiology 2001;94:8-14.
Collaborators WT. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet 2017;389:2105-16.
Committee on Practice B-O. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol 2017;130:e168-e86.
Sentilhes L, Senat MV, Le Lous M, Winer N, Rozenberg P, Kayem G, et al. Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery. N Engl J Med 2021;384:1623-34.
Ogunkua OT, Duryea EL, Nelson DB, Eddins MM, Klucsarits SE, McIntire DD, et al. Tranexamic acid for prevention of hemorrhage in elective repeat cesarean delivery-a randomized study. Am J Obstet Gynecol MFM 2022;4:100573.
Bellos I, Pergialiotis V. Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery: an updated meta-analysis. Am J Obstet Gynecol 2022;226:510-23 e22.
Neumann BG, Metgud MC, Hoffman MK, Patil K, Savanur M, Hanji V, et al. Tranexamic acid to reduce blood loss in women at high risk of postpartum hemorrhage undergoing cesarean delivery-a randomized controlled trial. AJOG Glob Rep 2024;4:100316.
Ortuanya KE, Eleje GU, Ezugwu FO, Odugu BU, Ikechebelu JI, Ugwu EO, et al. Prophylactic tranexamic acid for reducing intraoperative blood loss during cesarean section in women at high risk of postpartum hemorrhage: A double-blind placebo randomized controlled trial. Womens Health (Lond). 2024;20:17455057231225311.
Sentilhes L, Madar H, Le Lous M, Senat MV, Winer N, Rozenberg P, et al. Tranexamic acid for the prevention of blood loss after cesarean among women with twins: a secondary analysis of the TRAnexamic Acid for Preventing Postpartum Hemorrhage Following a Cesarean Delivery randomized clinical trial. Am J Obstet Gynecol 2022;227:889 e1- e17.
Gultekin M, Diribas K, Buru E, Gokceoglu MA. Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of patients with dysfunctional uterine bleeding. Clin Exp Obstet Gynecol 2009;36:163-5.
Abdou AM, Eldesouky E, Farag E, Mohammed A, Abdelaziz DFM, Shaaban A, et al. Oxytocin versus a combination of tranexamic acid and ethamsylate in reducing intraoperative bleeding during abdominal myomectomy: a randomized clinical trial. BMC Womens Health 2023;23:398.
Lukes AS, Moore KA, Muse KN, Gersten JK, Hecht BR, Edlund M, et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010;116:865-75.
Barseghyan M, Chae-Kim J, Catherino WH. The efficacy of medical management of leiomyoma-associated heavy menstrual bleeding: a mini review. F S Rep 2024;5:4-8.
Senthong AJ, Taneepanichskul S. The effect of tranexamic acid for treatment irregular uterine bleeding secondary to DMPA use. J Med Assoc Thai 2009;92:461-5.
Phupong V, Sophonsritsuk A, Taneepanichskul S. The effect of tranexamic acid for treatment of irregular uterine bleeding secondary to Norplant use. Contraception 2006;73:253-6.